Northfield Revenue and Competitors
Estimated Revenue & Valuation
- Northfield's estimated annual revenue is currently $16.6M per year.
- Northfield's estimated revenue per employee is $155,000
Employee Data
- Northfield has 107 Employees.
- Northfield grew their employee count by -7% last year.
Northfield's People
| Name | Title | Email/Phone |
|---|
Northfield Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Northfield?
We are a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute. The initial indication we are seeking for our product PolyHeme® is the treatment of life-threatening hemoglobin levels when blood transfusion is indicated but red blood cells may not be available, appropriate or acceptable. PolyHeme® is a solution of chemically modified human hemoglobin that requires no cross-matching and is therefore compatible with all blood types. It has an extended shelf life in excess of 12 months.
keywords:N/A
N/A
Total Funding
107
Number of Employees
$16.6M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.5M | 107 | -4% | N/A |
#2 | $10.7M | 107 | -8% | N/A |
#3 | $23.5M | 107 | 14% | N/A |
#4 | $28.9M | 107 | 2% | N/A |
#5 | $16.6M | 107 | 3% | N/A |